Requires that functional epinephrine auto-injector devices be made available in places of public assembly and that at least one employee or volunteer of such place of public assembly be trained in its proper operation and use and be present at each facility function.
Same As
Requires that functional epinephrine auto-injector devices be made available in places of public assembly and that at least one employee or volunteer of such place of public assembly be trained in its proper operation and use and be present at each facility function.
Requires that functional epinephrine auto-injector devices be made available in places of public assembly and that at least one employee or volunteer of such place of public assembly be trained in its proper operation and use and be present at each facility function.
Makes technical changes to certain provisions requiring epinephrine auto-injector devices to be made available in places of public assembly; amends the effectiveness of such provisions.
Makes technical changes to certain provisions requiring epinephrine auto-injector devices to be made available in places of public assembly; amends the effectiveness of such provisions.
Requires amusement device operators to be at least 16 years old, trained in the use and function of all normal and emergency operating controls, and the proper use of the amusement device; requires the operator to be in the immediate vicinity of the main control panel during operation of the amusement device; prohibits operators from operating more than one device at a time.
Requires amusement device operators to be at least 16 years old, trained in the use and function of all normal and emergency operating controls, and the proper use of the amusement device; requires the operator to be in the immediate vicinity of the main control panel during operation of the amusement device; prohibits operators from operating more than one device at a time.
Defines epinephrine device as a single-use device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.
Payment rates established for certain substance use disorder treatment services, and vendor eligibility recodified for payments from the behavioral health fund.
Cover Outstanding Vulnerable Expansion-eligible Residents Now Act or the COVER Now Act This bill establishes a demonstration program to allow local governments to provide health benefits to the Medicaid expansion population in states that have not expanded Medicaid. Under the program, local governments may provide coverage for individuals who are newly eligible for Medicaid under the Patient Protection and Affordable Care Act (i.e., the Medicaid expansion population) for a maximum of 10 years, or until their respective states expand Medicaid. The bill provides a 100% federal matching rate for the first three years of program participation. The bill prohibits states from taking certain actions against participating localities, such as withholding funding, increasing taxes, or restricting provider participation. States that violate these requirements are subject to certain funding penalties.